Parkinson's Disease Spatial Covariance Pattern: Noninvasive Quantification with Perfusion MRI

Parkinson's disease (PD) is associated with elevated expression of a specific disease-related spatial covariance pattern (PDRP) in radiotracer scans of cerebral blood flow and metabolism. In this study, we scanned nine early-stage patients with PD and nine healthy controls using continuous arterial spin labeling (CASL) perfusion magnetic resonance imaging (pMRI). Parkinson's disease-related metabolic pattern expression in CASL pMRI scans was compared with the corresponding 18F-fluorodeoxyglucose positron emission tomography values. The PDRP expression was abnormally elevated (P<0.01) in patients scanned with either modality, and the two values were highly intercorrelated (P<0.0001). Perfusion MRI methods can be used for accurate quantification of disease-related covariance patterns.

[1]  G. Alexander,et al.  The Metabolic Topography of Normal Aging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  J. Detre,et al.  Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. , 1998, Radiology.

[3]  John A Detre,et al.  Precision of the CASL‐perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories , 2003, Journal of magnetic resonance imaging : JMRI.

[4]  P. Tofts,et al.  Normal cerebral perfusion measurements using arterial spin labeling: Reproducibility, stability, and age and gender effects , 2004, Magnetic resonance in medicine.

[5]  Jiongjiong Wang,et al.  Continuous ASL (CASL) perfusion MRI with an array coil and parallel imaging at 3T , 2005, Magnetic resonance in medicine.

[6]  V. Dhawan,et al.  Network modulation in the treatment of Parkinson's disease. , 2006, Brain : a journal of neurology.

[7]  Koen Van Laere,et al.  Quantification of Parkinson’s disease-related network expression with ECD SPECT , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  V. Dhawan,et al.  Changes in network activity with the progression of Parkinson's disease. , 2007, Brain : a journal of neurology.

[9]  V. Dhawan,et al.  Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  V. Dhawan,et al.  Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[11]  David Eidelberg,et al.  Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease , 2008, The Journal of Neuroscience.

[12]  Yaakov Stern,et al.  Multivariate and Univariate Analysis of Continuous Arterial Spin Labeling Perfusion MRI in Alzheimer's Disease , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  Yaakov Stern,et al.  Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease , 2008, NeuroImage.

[14]  David Eidelberg,et al.  Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features , 2009, NeuroImage.

[15]  David Eidelberg,et al.  Network biomarkers for the diagnosis and treatment of movement disorders , 2009, Neurobiology of Disease.